Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
Hosted on MSN4h
FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with itOn Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...
With thousands of press releases published each week, it can be difficult to keep up with everything on. To help healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback